What is LOPJLB’s current signal on BNTC?

LOPJLB’s latest quantitative signal on Benitec Biopharma Inc. (BNTC) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is BNTC in?

Benitec Biopharma Inc. (BNTC) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Benitec Biopharma Inc. (BNTC) do?

Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and B…

Where is Benitec Biopharma Inc. based / listed?

Benitec Biopharma Inc. is based in US, listed on NASDAQ.

Benitec Biopharma Inc. (BNTC) Stock · BUY · RECOVERY

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $437M
Avg volume: 126.2K
Beta: 0.26
P/E (TTM): -11.45

Short % float: 6.41%
Days to cover: 26.7
SI change: -5.4%

1W: -2.75%
1M: +10.81%
3M: +13.18%
YTD: +0.95%

vs SPY 1W: -1.56%
vs SPY 1M: +7.49%
vs SPY 3M: +10.79%
vs SPY YTD: -10.80%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Benitec Biopharma Inc. (BNTC)

Key stats

Sector peers

Industry peers

Prediction markets

ANALYST & RATINGS

Company news